{"id":"W2898484591","doi":"10.1093/annonc/mdy424.009","title":"Overall survival (OS) with palbociclib plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Analyses from PALOMA-3","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Palbociclib; Fulvestrant; Internal medicine; Hazard ratio; Clinical endpoint; Breast cancer; Metastatic breast cancer; Progression-free survival; Oncology; Cancer; Gastroenterology; Chemotherapy; Estrogen receptor; Confidence interval; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000256709,0.000620658,0.001788221,0.0002880866,0.000154286,0.00001698833,0.0002974266,0.0002914747,0.001660407],"category_scores_gemma":[0.0000698349,0.0004684591,0.000120549,0.0006189718,0.001416131,0.0005141898,0.00008107857,0.0005578412,0.00002319508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008023793,"about_ca_system_score_gemma":0.0008400838,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005618894,"about_ca_topic_score_gemma":0.003601854,"domain_scores_codex":[0.996276,0.0003923325,0.0007875704,0.0009204299,0.0005760895,0.001047535],"domain_scores_gemma":[0.9967582,0.0004840787,0.0007599064,0.000477549,0.001108483,0.0004118112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.2206738,0.002622607,0.06603646,0.0002057557,0.006337023,0.0004563608,0.03463684,0.0002648293,0.4933505,0.0003302314,0.001112932,0.1739727],"study_design_scores_gemma":[0.02047805,0.0168494,0.8905897,0.0006006193,0.000150802,0.00005921739,0.00405334,0.00001367031,0.0637643,0.0006754124,0.001978931,0.0007866238],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910492,0.0006602368,0.0002452614,0.004549977,0.0001600286,0.0008333277,0.001213808,0.00008466542,0.001203554],"genre_scores_gemma":[0.9926968,0.0006450943,0.003674645,0.001726093,0.0005995174,0.0002666404,0.0001108376,0.0001077634,0.0001725963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8245532,"threshold_uncertainty_score":0.9997767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0559070896374383,"score_gpt":0.3822945158205199,"score_spread":0.3263874261830816,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}